Adrian is an economist, focussing on the use of valuebased pricing in drug/ vaccine reimbursement and the economics of innovation. He is a Visiting Professor in Practice at the London School of Economics.

Adrian’s current research interests include incentives for new drugs and vaccines to tackle Antimicrobial Resistance; the use of ‘risksharing’ arrangements between health care payers and pharmaceutical companies, measuring novel elements of value and the use of valuebased pricing; the economics of stratified medicine for health care payers and the pharmaceutical industry; and economic issues that affect both R&D for and access to treatments for diseases prevalent in the low and middle income countries.